Skip to main content

New Rules for French Startups: Tax Changes to Boost Le Biotech

NEW YORK, Dec. 11-The French government today proposed new tax policies for startup companies that should provide a boost to that country's biotechnology industry.

 

In an announcement this morning, the French Industry Ministry and the Ministry of Research and New Technologies detailed a suite of new tax exemptions designed to provide a leg up for new technology companies.

 

Under this plan, startups-or Jeunes Entreprises Innovantes, as the French ministry terms them-will benefit from a range of business-friendly policies:

 

· R&D startups less than eight years old will pay no corporate income tax

· Taxes on venture capital R&D investments will be eliminated

· Reductions on other social charges and local taxes

· Other measures will encourage researchers to patent discoveries

· Students will be encouraged to explore careers in industry

 

France also intends to propose additional measures promoting innovative industries to the European Council in the spring.

 

Cooperation between industry and research in France is not strong enough, said the research ministry in a statement, and the government must help foster innovation. This role is "complementary to a liberal political economy," the ministry said.

 

As part of these efforts, the ministry is also urging that national investment in R&D be increased from 2.2 percent of GDP to 3 percent by 2010.

 

France Biotech, the French industry group, welcomed the measures. The new rules will ease high-tech investing in the country, the group said.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.